WallStSmart

Northrop Grumman Corporation (NOC)vsRelx PLC ADR (RELX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Northrop Grumman Corporation generates 342% more annual revenue ($42.37B vs $9.59B). RELX leads profitability with a 21.5% profit margin vs 10.8%. RELX appears more attractively valued with a PEG of 1.46. NOC earns a higher WallStSmart Score of 63/100 (C+).

NOC

Buy

63

out of 100

Grade: C+

Growth: 6.0Profit: 7.0Value: 3.3Quality: 4.5
Piotroski: 3/9Altman Z: 1.96

RELX

Buy

62

out of 100

Grade: C+

Growth: 5.3Profit: 9.0Value: 7.3Quality: 3.8
Piotroski: 4/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NOCSignificantly Overvalued (-61.6%)

Margin of Safety

-61.6%

Fair Value

$419.98

Current Price

$572.41

$152.43 premium

UndervaluedFair: $419.98Overvalued
RELXUndervalued (+60.0%)

Margin of Safety

+60.0%

Fair Value

$72.16

Current Price

$36.59

$35.57 discount

UndervaluedFair: $72.16Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NOC3 strengths · Avg: 9.3/10
EPS GrowthGrowth
84.9%10/10

Earnings expanding 84.9% YoY

Market CapQuality
$81.68B9/10

Large-cap with strong market position

Return on EquityProfitability
28.5%9/10

Every $100 of equity generates 29 in profit

RELX5 strengths · Avg: 9.2/10
Return on EquityProfitability
70.5%10/10

Every $100 of equity generates 71 in profit

Operating MarginProfitability
31.4%10/10

Strong operational efficiency at 31.4%

Market CapQuality
$65.06B9/10

Large-cap with strong market position

Profit MarginProfitability
21.5%9/10

Keeps 22 of every $100 in revenue as profit

Free Cash FlowQuality
$1.48B8/10

Generating 1.5B in free cash flow

Areas to Watch

NOC4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
4.4%4/10

4.4% revenue growth

Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Debt/EquityHealth
1.183/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

RELX3 concerns · Avg: 2.3/10
Revenue GrowthGrowth
1.2%4/10

1.2% revenue growth

Price/BookValuation
83.2x2/10

Trading at 83.2x book value

Debt/EquityHealth
3.101/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : NOC

The strongest argument for NOC centers on EPS Growth, Market Cap, Return on Equity.

Bull Case : RELX

The strongest argument for RELX centers on Return on Equity, Operating Margin, Market Cap. Profitability is solid with margins at 21.5% and operating margin at 31.4%. PEG of 1.46 suggests the stock is reasonably priced for its growth.

Bear Case : NOC

The primary concerns for NOC are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : RELX

The primary concerns for RELX are Revenue Growth, Price/Book, Debt/Equity. Debt-to-equity of 3.10 is elevated, increasing financial risk.

Key Dynamics to Monitor

RELX carries more volatility with a beta of 0.23 — expect wider price swings.

NOC is growing revenue faster at 4.4% — sustainability is the question.

RELX generates stronger free cash flow (1.5B), providing more financial flexibility.

Monitor AEROSPACE & DEFENSE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NOC scores higher overall (63/100 vs 62/100). RELX offers better value entry with a 60.0% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Northrop Grumman Corporation

INDUSTRIALS · AEROSPACE & DEFENSE · USA

Northrop Grumman Corporation (NYSE: NOC) is an American multinational aerospace and defense technology company.

Visit Website →

Relx PLC ADR

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

RELX PLC provides information-based decision-making and analysis tools for professional and commercial clients in North America, Europe, and internationally. The company is headquartered in London, the United Kingdom.

Visit Website →

Want to dig deeper into these stocks?